Joseph Madri, MD/PhD
Professor Emeritus of PathologyCards
About
Titles
Professor Emeritus of Pathology
Appointments
Pathology
EmeritusPrimary
Other Departments & Organizations
- Dean's Workshops
- Madri Lab
- NIH T32 Program
- Pathology
- Pathology and Molecular Medicine
- Pathology Research
- Yale Cancer Center
- Yale Stem Cell Center
- Yale Ventures
Education & Training
- Fellow
- Yale University School of Medicine (1980)
- Resident
- Yale-New Haven Hospital (1977)
- MD/PhD
- Indiana University, Biological Chemistry and Medicine (1975)
Research
Overview
Research Focus: The interests of my laboratory center around investigations of signaling pathways stimulated following endothelial cell-cell and endothelial cell-extracellular interactions and how they influence the processes of vasculogenesis, angiogenesis and transendothelial migration.
Endothelial cells play central roles in the development, growth and maintenance of the vascular system as well as in the processes of inflammation, repair and metastasis. Vascular cell homotypic and heterotypic interactions and vascular cell interactions with the surrounding matrix, soluble factors and circulating blood cells (leukocytes, monocytes and lymphocytes), in part, direct the vascular cells' responses; yet little is known about these complex interactions and the mechanisms involved in information transduction from the extracellular environment to the cell nucleus.
We are currently investigating the roles of selected homotypic and heterotypic cell adhesion molecules (PECAM-1 & CD44), integrins (selected beta1, beta 2 and beta 3 integrins), junction associated molecules (VE-cadherin, ZO-1, Occludin) and extracellular matrix components (MMPs) in modulating vascular cell and T cell behavior (attachment, spreading, proliferation, migration, interactions with mononuclear (T) cells and angiogenesis).
Specific projects in the laboratory currently include:
1) Elucidation of the roles of the cytoplasmic domains of Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1/CD31) and CD44 in modulating endothelial and T cell behavior, vascular development and dermal wound healing as well as the signaling mechanisms involved. We are investigating how differential tyrosine and serine phosphorylation of the PECAM-1 cytoplasmic domain modulates associations with specific proteins including beta- and gamma-catenin; STAT3&5, c-src, SHP-2 and small G proteins. We are also investigating the dynamic interactions between CD44 and CD31.
2) Identification and elucidation of the signal transduction pathways activated following T cell-endothelial cell binding and subsequent CD44 and PECAM-1 signaling prior to, during and following T cell transmigration into tissues. We are investigating the mechanisms of induction, clustering and activation of T cell and endothelial cell matrix metalloproteinase-2 [MMP-2 ], membrane type matrix metalloproteinase [MT1-MMP/MMP-14], matrix metalloproteinases [MMP-9] and CD44. Selected knock out mouse strains (CD44 KO) are also utilized in animal models of autoimmune encephalomyelitis.
3) Elucidation of the mechanisms of hypoxia-driven cerebral angiogenic responses noted in the premature infant population and their association with neurodevelopmental handicaps. Animal, organ and tissue culture models of chronic hypoxia, coupled with cDNA array analysis, are used to investigate the responses of the cerebral microvascular endothelial cells and the roles of the vasculature in causing resultant neurodevelopmental handicaps. The dynamic roles of HIF-1alpha and Sox10 in endothelial and neural stem cell responses to, and recovery from, hypoxic insult are being investigated.
1) Elucidation of the mechanisms involved in the recovery of neurodevelopmental handicaps incurred during and following premature birth and recovery from spinal cord injury.
3) Elucidation of the mechanisms involved in lymphocyte transmigration through endothelial cells during inflammation.
4) Elucidation of the roles of PECAM-1 (CD31) and CD44 in vasculo- and angiogenesis, permeability, inflammation, directed migration, hemostasis and hematopoiesis and bone metabolism.
Medical Research Interests
Academic Achievements & Community Involvement
News & Links
News
- June 24, 2024
Foundation Created by Joseph Madri, MD/PhD, Professor Emeritus of Pathology, Supports Many Causes
- April 12, 2022
Yale Pathology Meets in Madison for Department Retreat; First In-Person Gathering Since Pandemic Began
- January 31, 2017
New endowed professorship established in experimental pathology
- November 12, 2014
Can resilience be engineered?